Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:02 AM
NCT ID: NCT01440920
Description: None
Frequency Threshold: 5
Time Frame: Treatment-emergent adverse events were collected from start of the first IMP administration (Day 1) to Post-treatment observation (Day 50).
Study: NCT01440920
Study Brief: A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Cohort 1 subcutaneously administered once a week, 4 times at the dose of 0.3 mg 0 None 0 3 3 3 View
Cohort 2 subcutaneously administered once a week, 4 times at the dose of 1 mg 0 None 0 3 3 3 View
Cohort 3 subcutaneously administered once a week, 4 times at the dose of 3 mg 0 None 0 3 3 3 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site induration NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA Ver. 14.0 View
Injection site mass NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA Ver. 14.0 View
Injection site pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA Ver. 14.0 View
Injection site pruritus NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA Ver. 14.0 View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Ver. 14.0 View
Eosinophil count increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA Ver. 14.0 View
Lymphocyte count decreased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA Ver. 14.0 View
Neutrophil count decreased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA Ver. 14.0 View
Platelet count decreased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA Ver. 14.0 View
White blood cell count decreased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA Ver. 14.0 View
Protein urine present NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA Ver. 14.0 View
Hyperlipidaemia NON_SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA Ver. 14.0 View
Joint swelling NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA Ver. 14.0 View
Dizziness NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Ver. 14.0 View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Ver. 14.0 View
Hypoaesthesia NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Ver. 14.0 View
Dermatitis NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Ver. 14.0 View
Erythema NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Ver. 14.0 View
Anaemia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA Ver. 14.0 View
Leukopenia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA Ver. 14.0 View
Lymphopenia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA Ver. 14.0 View
Neutropenia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA Ver. 14.0 View
Thrombocytopenia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA Ver. 14.0 View
Cataract NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA Ver. 14.0 View
Vitreous floaters NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA Ver. 14.0 View
Stomatitis NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Ver. 14.0 View
Injection site erythema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA Ver. 14.0 View